PUFA-derived endocannabinoids: an overview

Maria Grazia Cascio

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Following on from the discovery of cannabinoid receptors, of their endogenous agonists (endocannabinoids) and of the biosynthetic and metabolic enzymes of the endocannabinoids, significant progress has been made towards the understanding of the role of the endocannabinoid system in both physiological and pathological conditions. Endocannabinoids are mainly n-6 long-chain PUFA (LCPUFA) derivatives that are synthesised by neuronal cells and inactivated via a two-step process that begins with their transport from the extracellular to the intracellular space and culminates in their intracellular degradation by hydrolysis or oxidation. Although the enzymes responsible for the biosynthesis and metabolism of endocannabinoids have been well characterised, the processes involved in their cellular uptake are still a subject of debate. Moreover, little is yet known about the roles of endocannabinoids derived from n-3 LCPUFA such as EPA and DHA. Here, I provide an overview of what is currently known about the mechanisms for the biosynthesis and inactivation of endocannabinoids, together with a brief analysis of the involvement of the endocannabinoids in both food intake and obesity. Owing to limited space, recent reviews will be often cited instead of original papers.
Original languageEnglish
Pages (from-to)451-459
Number of pages9
JournalProceedings of the Nutrition Society
Volume72
Issue number4
Early online date11 Sep 2013
DOIs
Publication statusPublished - Nov 2013

Fingerprint

Endocannabinoids
Intracellular Space
Cannabinoid Receptors
Enzymes
Hydrolysis
Obesity
Eating

Keywords

  • anandamide
  • 2-arachidonoyl-glycerol
  • cannabinoid receptors
  • food intake
  • obesity

Cite this

PUFA-derived endocannabinoids : an overview. / Cascio, Maria Grazia.

In: Proceedings of the Nutrition Society, Vol. 72, No. 4, 11.2013, p. 451-459.

Research output: Contribution to journalArticle

Cascio, Maria Grazia. / PUFA-derived endocannabinoids : an overview. In: Proceedings of the Nutrition Society. 2013 ; Vol. 72, No. 4. pp. 451-459.
@article{d87ef7028f354ff5a6eda562598ec1e6,
title = "PUFA-derived endocannabinoids: an overview",
abstract = "Following on from the discovery of cannabinoid receptors, of their endogenous agonists (endocannabinoids) and of the biosynthetic and metabolic enzymes of the endocannabinoids, significant progress has been made towards the understanding of the role of the endocannabinoid system in both physiological and pathological conditions. Endocannabinoids are mainly n-6 long-chain PUFA (LCPUFA) derivatives that are synthesised by neuronal cells and inactivated via a two-step process that begins with their transport from the extracellular to the intracellular space and culminates in their intracellular degradation by hydrolysis or oxidation. Although the enzymes responsible for the biosynthesis and metabolism of endocannabinoids have been well characterised, the processes involved in their cellular uptake are still a subject of debate. Moreover, little is yet known about the roles of endocannabinoids derived from n-3 LCPUFA such as EPA and DHA. Here, I provide an overview of what is currently known about the mechanisms for the biosynthesis and inactivation of endocannabinoids, together with a brief analysis of the involvement of the endocannabinoids in both food intake and obesity. Owing to limited space, recent reviews will be often cited instead of original papers.",
keywords = "anandamide , 2-arachidonoyl-glycerol, cannabinoid receptors, food intake , obesity",
author = "Cascio, {Maria Grazia}",
year = "2013",
month = "11",
doi = "10.1017/S0029665113003418",
language = "English",
volume = "72",
pages = "451--459",
journal = "Proceedings of the Nutrition Society",
issn = "0029-6651",
publisher = "Cambridge Univ. Press.",
number = "4",

}

TY - JOUR

T1 - PUFA-derived endocannabinoids

T2 - an overview

AU - Cascio, Maria Grazia

PY - 2013/11

Y1 - 2013/11

N2 - Following on from the discovery of cannabinoid receptors, of their endogenous agonists (endocannabinoids) and of the biosynthetic and metabolic enzymes of the endocannabinoids, significant progress has been made towards the understanding of the role of the endocannabinoid system in both physiological and pathological conditions. Endocannabinoids are mainly n-6 long-chain PUFA (LCPUFA) derivatives that are synthesised by neuronal cells and inactivated via a two-step process that begins with their transport from the extracellular to the intracellular space and culminates in their intracellular degradation by hydrolysis or oxidation. Although the enzymes responsible for the biosynthesis and metabolism of endocannabinoids have been well characterised, the processes involved in their cellular uptake are still a subject of debate. Moreover, little is yet known about the roles of endocannabinoids derived from n-3 LCPUFA such as EPA and DHA. Here, I provide an overview of what is currently known about the mechanisms for the biosynthesis and inactivation of endocannabinoids, together with a brief analysis of the involvement of the endocannabinoids in both food intake and obesity. Owing to limited space, recent reviews will be often cited instead of original papers.

AB - Following on from the discovery of cannabinoid receptors, of their endogenous agonists (endocannabinoids) and of the biosynthetic and metabolic enzymes of the endocannabinoids, significant progress has been made towards the understanding of the role of the endocannabinoid system in both physiological and pathological conditions. Endocannabinoids are mainly n-6 long-chain PUFA (LCPUFA) derivatives that are synthesised by neuronal cells and inactivated via a two-step process that begins with their transport from the extracellular to the intracellular space and culminates in their intracellular degradation by hydrolysis or oxidation. Although the enzymes responsible for the biosynthesis and metabolism of endocannabinoids have been well characterised, the processes involved in their cellular uptake are still a subject of debate. Moreover, little is yet known about the roles of endocannabinoids derived from n-3 LCPUFA such as EPA and DHA. Here, I provide an overview of what is currently known about the mechanisms for the biosynthesis and inactivation of endocannabinoids, together with a brief analysis of the involvement of the endocannabinoids in both food intake and obesity. Owing to limited space, recent reviews will be often cited instead of original papers.

KW - anandamide

KW - 2-arachidonoyl-glycerol

KW - cannabinoid receptors

KW - food intake

KW - obesity

U2 - 10.1017/S0029665113003418

DO - 10.1017/S0029665113003418

M3 - Article

VL - 72

SP - 451

EP - 459

JO - Proceedings of the Nutrition Society

JF - Proceedings of the Nutrition Society

SN - 0029-6651

IS - 4

ER -